Figure 3. Distributions of a priori predicted probability of sustained virological response (SVR) for 554 non-responders and 92 subjects who achieved SVR - European American patients infected with HCV genotype 1, HALT-C Trial.

Predicted probabilities are based on a series of leave-one-out cross-validation logistic regression models.